A Safety, Tolerability, and Pharmacokinetics (PK) Study of AGN-223575 in Healthy Subjects

Study Identifier
223575-001
CT.gov Identifier
NCT02155543
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Healthy Volunteer
    • Study Drug
  • AGN-223575 Formulation A
  • AGN-223575 Formulation B
  • AGN-223575 Formulation C
  • AGN-223575 Vehicle
    • Phase
    Phase 1
    Sex
    Female & Male
    Age
    18 - 65 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Weight at least 110 lbs
    Exclusion Criteria:
    * Use of contact lenses within 14 days, or planned use during the study * Use of any ocular eye medications within 30 days, or anticipated use during the study * Anticipated use of any artificial tears product during the study

    Protocol Summary

    This study will evaluate the safety, tolerability, and pharmacokinetics (PK) of AGN-223575 in healthy subjects.

    Study Locations

    Location
    Status
    Location
    Newport Beach, California, United States
    Status
    Not applicable